Armata Pharmaceuticals, Inc. (ARMP)
5.595
-0.04
(-0.62%)
USD |
NYAM |
Dec 08, 16:00
5.595
0.00 (0.00%)
After-Hours: 18:44
Armata Pharmaceuticals Shareholders Equity (Quarterly): -95.59M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -274.14M |
| Integer Holdings Corp. | 1.746B |
| Liquidia Corp. | 22.05M |
| AIM ImmunoTech, Inc. | -6.077M |
| Protalix Biotherapeutics, Inc. | 52.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.52M |
| Total Liabilities (Quarterly) | 185.10M |
| Debt to Equity Ratio | -1.859 |
| Current Ratio | 0.121 |
| Net Debt Paydown Yield | -5.84% |